No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers-Reference-Cited by-同舟云学术

No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers

Published:2003 Issue:5 Volume:42 Page:475-484
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clinical Pharmacokinetics

Author:

Johansson Linda C,Andersson Magnus,Fager Gunnar,Gustafsson David,Eriksson Ulf G

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans

2. The Importance of Enzyme Inhibition Kinetics for the Effect of Thrombin Inhibitors in a Rat Model of Arterial Thrombosis

3. Antithrombotic Effects and Bleeding Time of Thrombin Inhibitors and Warfarin in the Rat

4. Effects of Melagatran, a New Low-molecular-weight Thrombin Inhibitor, on Thrombin and Fibrinolytic Enzymes

5. Melagatran, An Oral Active-Site Inhibitor of Thrombin, Prevents or Delays Formation of Electrically Induced Occlusive Thrombus in the Canine Coronary Artery

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombin inhibitors, direct;Meyler's Side Effects of Drugs;2016

2. Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects;Biopharmaceutics & Drug Disposition;2013-09-20

3. Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation;Drug Metabolism and Pharmacokinetics;2013

4. Oral Direct Thrombin Inhibitors and Oral Factor Xa Inhibitors;Therapeutic Advances in Thrombosis;2012-10-03

5. Prevention and Treatment of Venous Thromboembolism and Pulmonary Embolism: The Role of Novel Oral Anticoagulants;Current Clinical Pharmacology;2012-06-01